According to the Standing Vaccination Commission (Stiko), anyone who has been vaccinated with the corona vaccine from Johnson & Johnson should receive an additional dose of mRNA vaccine for better protection. The panel of experts announced on Thursday that this could be done from four weeks after the Johnson & Johnson vaccination.
As a justification, the Stiko referred to so-called vaccination breakthroughs: In relation to the number of doses administered, most of these infections were recorded in people vaccinated with Johnson & Johnson in Germany. The effectiveness against the delta variant prevailing in this country is comparatively low in contrast to the other corona vaccines, it said. The Stiko ultimately speaks of insufficient vaccination protection.
3.2 million vaccinated in Germany with Johnson & Johnson vaccine
Carsten Watzl, Secretary General of the German Society for Immunology, emphasized some time ago that the Johnson & Johnson vaccine could very well protect against severe corona disease.
It is not yet a final Stiko recommendation. A corresponding draft resolution had gone into coordination with specialist groups and federal states, it said. Changes are therefore still possible.
In the case of the Johnson & Johnson vaccine, one dose was previously considered sufficient for full vaccination protection, while with the other approved vaccines two syringes were initially given. In data from the Robert Koch Institute (RKI) as of Thursday, more than 3.2 million vaccinations with Johnson & Johnson have been recorded.